Company Analysis

Ensysce Biosciences, Inc. (ENSC)

Nasdaq: ENSC · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2017
Grade3.8
◀ Past 1.8● Present 3.5▶ Future 5.2
2 est.

Who runs Ensysce Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
1
of 2 people with a filing in the last fifteen months
Directors reporting now
1
23 people on the record since 2017
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Morrison James WilliamPresidentAug 2026Aug 10, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Gower Bob GdirectorJun 2021Aug 18, 2026none
Earlier names on the record26, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ENSC · research, not advice